Egnyte Announces Solution for Trial Operations
Egnyte has announced Egnyte for Life Sciences eTMF, a product for the clinical development functions at life science companies to manage trial master file data. Egnyte for Life Sciences eTMF is 21 CFR Part 11 compliant solution that aims to reduce document processing time while maintaining compliance and audit readiness.
Egnyte for Life Sciences eTMF solution enables clinical development professionals to:
- Stay on track with milestones: built on Egnyte’s secure collaboration platform, get full visibility into study milestones, allowing clinical teams to communicate with sites to stick to timelines.
- Maintain control of trial information: Egnyte’s governance features allow teams to flag missing source documents, leverage AI and ML features for constant monitoring for misclassified documents or embedded PII/PHI.
- Be audit-ready and compliant: meeting GxP and FDA 21 CFR Part 11 requirements, Egnyte allows companies to stay audit-ready and maintain compliance in a cloud-based solution.
More about Egnyte for Life Sciences eTMF
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
